Tech Sector Uplifts US Equities Oil Prices Slide on Prospects of Iran Nuclear Deal Credit Suisses Neelkanth Mishra Sees Scope for Meaningful Rate Cuts Anticipates Market PickUp from December Trumps Mixed Signals on Iran Deal Keep Oil Markets on Edge From Hype to Returns How Enterprises Are Navigating the AI ROI Challenge Wall Street Futures Rise on USIran Optimism and AI Rebound SP 500 Targets Eighth Straight Weekly Gain Prairie Operating PROP Faces NearTerm Headwinds but LongTerm Outlook Remains Intact MRVI Q1 2026 Earnings EPS Surprise of 12079 Drives Focus on Cost Control Amid Revenue Uncertainties EVH Q1 2026 Earnings EPS Surpasses Expectations with 614 Surprise XFOR Q1 2026 Earnings EPS Beats Estimates Despite Continued PreRevenue Status Stock Declines Blackstone Secured Lending Fund BXSL Q1 2026 Earnings EPS Beat Driven by Strong Investment Income and Portfolio Performance Phreesia Q1 2026 Earnings Profitability Misses Estimates Despite Stock Uplift ADAMH Q1 2026 Earnings Strong EPS Surprise Highlights Solid Underlying Performance AEON Biopharma Dips 274 as Stock Nears Critical Support at 076 Fox Corporation FOXA Consolidates Near Support Amid Modest Downtrend Johnson Outdoors Inc JOUT Gains 147 as Shares Test MidRange Territory Gauzy Ltd GAUZ Slides Further as Shares Test Key Support Level Amylyx Pharmaceuticals AMLX Slips 25 as Biotech Sector Faces Renewed Scrutiny Haoxi Health Technology Limited HAO Plunges 16 Key Levels to Watch Delek Logistics Partners DKL Breaks Below Key ShortTerm Support Amid Energy Sector Weakness Daedalus Special Acquisition Corp DSAC Holds Steady Near Trust Value as MA Speculation Builds Personalis Inc PSNL Surges 77 as Precision Medicine Stock Approaches Key Resistance Fox Factory FOXF Jumps 264 as Shares Approach Key Resistance Level Studio City International MSC Edges Lower Amid Quiet Trading Key Support Levels in Focus Applied Digital Releases Fiscal Third Quarter 2026 Results AI Infrastructure Focus Continues ENR Q1 2026 Earnings EPS Surges Past Estimates by Over 100 Tarsus Pharmaceuticals TARS Shows Resilience Near Support After Moderate Decline